A review of relevant law reveals that the Trump administration is not nearly as hampered by antitrust law as the pharmaceutical benefits manager industry argues. Antitrust law does not prohibit manufacturers from offering discounts on drug prices, and antitrust law cannot justify the industry’s current aggressive use of rebates,...
The Implications of “Medicare for All” for US Hospitals
Medicare for All’s impact on hospitals would be significant, including a 15.9% reduction in revenue and 1.5 million jobs lost, unless hospitals quickly became more efficient, according to a piece by Arnold Milstein & Kevin Schulman in the latest issue of JAMA: https://bit.ly/2uMiidU
Understanding high drug costs and the role of pharmacy benefit managers
Kevin Schulman writes in a Stanford Medicine article that although consumers may benefit by having an intermediary help to secure the best prices for medications, questions persist about how much should be paid for this service, and how transparent the whole market should be. Read more
Toward an Effective Innovation Agenda
Kevin A. Schulman, M.D., and Barak D. Richman, J.D., Ph.D. Why have investments in digital technologies largely failed to reduce healthcare costs and improve population health, the patient experience and the lives of healthcare professionals? And why have digital technologies had so little systemic impact? https://www.nejm.org/doi/full/10.1056/NEJMp1812460
Stop Outrageous Air Ambulance Bills by Disclosing the Transport Price – By Kevin Schulman, Barak Richman, and Arnold Milstein
Stop outrageous air ambulance bills by disclosing the transport price
The Relationship between Pharmacy Benefit Managers (PBMs) and the Cost of Therapies in the US Pharmaceutical Market: A Policy Primer for Clinicians
Kevin A.Schulman MD, MBA & Matan Dabora MD, MBA https://www.sciencedirect.com/science/article/pii/S0002870318302485?via%3Dihub#!
Watch for Motorcycles! The Effects of Texting and Handheld Bans on Motorcyclist Fatalities
Michael T. French, University of Miami, Departments of Health Management and Policy, Sociology, Economics, and Public Health Sciences, and Gulcin Gumus, Department of Management Programs, Florida Atlantic University https://www.sciencedirect.com/science/article/abs/pii/S0277953618305227?via%3Dihub
Do Skilled Nursing Facilities Selected to Participate in Preferred Provider Networks Have Higher Quality and Lower Costs?
Peter J. Huckfeldt Ph.D. Lianna Weissblum B.A. José J. Escarce M.D., Ph.D. Pinar Karaca‐Mandic Ph.D. Neeraj Sood Ph.D. https://onlinelibrary.wiley.com/doi/abs/10.1111/1475-6773.13027
The Impact of Off-Patent Drug Acquisitions on Prices
Gupta R, Henkel A, Forman HP, Ross JS: The Impact of Off-Patent Drug Acquisitions on Prices. J Gen Intern Med. 2018 Apr 23; 2018 Apr 23. PMID: 29687433 https://www.ncbi.nlm.nih.gov/pubmed/29687433
Administrative Costs Associated with Physician Billing and Insurance-Related Activities at an Academic Health Care System
Phillip Tseng, MEd; Robert S. Kaplan, PhD; Barak D. Richman, JD, PhD; Mahek A. Shah, MD; Kevin A. Schulman, MD https://jamanetwork.com/journals/jama/fullarticle/2673148